Skip to main content

Key Product Details

Validated by

Independent Antibodies, Biological Validation

Species Reactivity

Validated:

Human, Mouse

Cited:

Mouse

Predicted:

Rat (100%). Backed by our 100% Guarantee.

Applications

Validated:

Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Western Blot

Cited:

Immunocytochemistry/ Immunofluorescence, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Concentration

1.0 mg/ml

Product Specifications

Immunogen

The immunogen recognized by this antibody maps to a region between residues 1850 and 1900 of human Dedicator of Cytokinesis 9 using the numbering given in entry NP_056111.1 (GeneID 23348).

Localization

Cytoplasmic (membrane associated)

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Theoretical MW

236 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Scientific Data Images for DOCK9 Antibody

Western Blot: DOCK9 Antibody [NB500-265]

Western Blot: DOCK9 Antibody [NB500-265]

Western Blot: DOCK9 Antibody [NB500-265] - Expression profile of Zizimin1 and Zizimin2 protein. Western blot analysis shows the expression levels of Zizimin1 and Zizimin2 in murine tissues described at the top of the panels. alpha-Tubulin was used as a loading control. Image collected and cropped by CiteAb from the following publication (immunityageing.biomedcentral.com/articles/10.1186/1742-4933-9-2), licensed under a CC-BY license.
Western Blot: DOCK9 Antibody [NB500-265]

Western Blot: DOCK9 Antibody [NB500-265]

Western Blot: DOCK9 Antibody [NB500-265] - Detection of Human and Mouse DOCK9 by Western Blot. Samples: Whole cell lysate (50 ug) from HeLa, 293T, and mouse NIH3T3 cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-DOCK9 antibody NB500-265 used for WB at 1 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.
Western Blot: DOCK9 Antibody [NB500-265]

Western Blot: DOCK9 Antibody [NB500-265]

Western Blot: DOCK9 Antibody [NB500-265] - Zizimin2, Zizimin1, and Zizimin3 expression in young and aged mice. Lysates were prepared from three individual three young (7-8 weeks old) or aged (24 months old) mouse tissues, which are described to the left of each panel, followed by western blotting. alpha-Tubulin was used as a loading control. Image collected and cropped by CiteAb from the following publication (immunityageing.biomedcentral.com/articles/10.1186/1742-4933-9-2), licensed under a CC-BY license.

Applications for DOCK9 Antibody

Application
Recommended Usage

Immunoprecipitation

2-10 ug/mg lysate

Western Blot

1:500-1:2500

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

Tris-Citrate/Phosphate (pH 7.0 - 8.0)

Preservative

0.09% Sodium Azide

Concentration

1.0 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C. Do not freeze.

Background: DOCK9

DOCK9 is a guanine nucleotide-exchange factor (GEF) that activates CDC42 by exchanging bound GDP for free GTP. Its overexpression induces filopodia formation.

Alternate Names

Cdc42 guanine nucleotide exchange factor zizimin-1, dedicator of cytokinesis 9, dedicator of cytokinesis protein 9, DKFZp686C11110, DKFZp686D2047, DKFZp686N04132, FLJ11949, FLJ16744, FLJ45601, KIAA1058FLJ44528, KIAA1085, ZIZ1FLJ45282, ZIZIMIN1

Entrez Gene IDs

23348 (Human)

Gene Symbol

DOCK9

UniProt

Additional DOCK9 Products

Product Documents for DOCK9 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for DOCK9 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...
Loading...